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Prolonged fructose intake can activate the renin-angiotensin-aldosterone system and enhance oxidative
stress conditions, causing hypertension and hyperuricemia. This study aimed to determine the
antihypertensive and antioxidant activity of Jamu B on the activity of superoxide dismutase (SOD),
level of glutathione (GSH), and malondialdehyde (MDA) in the kidneys of Sprague Dawley rats
induced by 10% fructose. Thirty rats were divided into six groups. Groups B1-B3 were Jamu groups at
a dose of 0.12 g/kg BW (B1), 0.24 g/kg BW (B2), and 0.36 g/kg BW (B3); group C (positive control)
was given captopril 0.1 g/kg BW, group D (negative control) was given only 10% fructose, and group E
(normal control) was healthy rats. The 10% fructose was induced for eight weeks and the treatment was
given on the week 9th and 10th. Jamu B reduced systolic and diastolic blood pressure at all doses, but was
not significantly different from the normal control group (p>0.05). The SOD activity in groups B1, B2,
B3, and C was significantly different from the negative control group (p<0.05). However, GSH levels
only showed a significant difference between B2, B3, C, and the negative control group (p<0.05). The
MDA levels only showed a significant difference between B3 and the negative control group (p<0.05).
Jamu B at the dose of 0.12 g/kg BW, 0.24 g/kg BW, and 0.36 g/kg BW have antihypertensive and
antioxidant activity in the kidneys of rats induced by 10% fructose. Nevertheless, Jamu B at a dose of
0.36 g/kg BW was the most effective as an antihypertensive and antioxidant agent.
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INTRODUCTION
Kidneys play an essential role in excreting the body’s
metabolic wastes. These organs are susceptible to damage
due to excess free radicals or oxidative stress (Dornas
et al., 2017). A recent study has shown that continuous
fructose administration in rats can increase oxidative
stress, uric acid production, and inflammation that induce
glomerular hypertension and kidney damage (Nakagawa
et al., 2020). Excessive fructose consumption causes
hyperuricemia, hyperinsulinemia, and hypertension,
leading to impaired kidney function. Fructose also
increases sympathetic nerve activity. It also produces
vasoconstrictors, like endothelin-1, angiotensin II, and
prostanoids, and decreases nitric oxide (NO) levels,
contributing to endothelium dysfunction (Sánchezlozada et al., 2012). Several in-vivo studies in rats
have shown that an increase in free radicals, including
superoxide anions and nitric oxide, can cause lipid and
protein oxidation which was observed in cases of kidney
damage. Thus, overconsumption of fructose would
raise free radicals production and subsequently impacts
the development of kidney disease by decreasing the
activity of superoxide dismutase (SOD), glutathione
peroxidase (GPx), and selenium (Dennis & Witting,
2017). The antioxidant compound is necessary to protect

the body from oxidative stress and stabilize free radicals
by donating one electron to free radical compounds.
The human body has its defense mechanism to fight
free radicals and oxidative stress through endogenous
antioxidants, SOD, and glutathione (GSH) enzymes,
yet under oxidative stress conditions, the amount is
insufficient to overcome the excess of free radicals.
Therefore, adding exogenous antioxidants, such as
herbal medicines, is required to impede oxidative stress
activity (Dennis & Witting, 2017; Azab et al., 2017).
Jamu B, a herbal medicine, contained Curcuma
xanthorriza rhizome (Temulawak), Andrographis
paniculata herb (Sambiloto), Tinospora crispa caulis
(Brotowali), Orthosiphon stamineus folium (Kumis
Kucing), and Phyllanthus niruri folium (Meniran), is
indicated as antihypertensive. Interestingly, a previous
in vitro study on Jamu B has shown antioxidant activity
with an IC50 value of 11.4 ppm (Eff, Hurit, et al., 2020;
Eff, Rahayu, et al., 2020). The study conducted by Eff,
Rahayu, et al. (2020) also showed that Jamu B has an
antihypertensive effect through its mechanism as an
ACE inhibitor with an IC50 value of 103.75 µg/ml. Jamu
B extracts contain flavonoid compounds, alkaloids,
tannins, saponins, steroids, and triterpenoids (Eff,
Rahayu, et al., 2020). The flavonoid and polyphenolic
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metabolites in Jamu can improve kidney function by
reducing oxidative damage and increasing the activity of
antioxidant enzymes, including SOD and GSH (Zeng et
al., 2019).
Hence, this study aimed to determine the antihypertensive
and antioxidant activity of Jamu B; with the composition
of Curcuma xanthorriza rhizome 1500 mg, Andrographis
paniculata herb 1200 mg, Tinospora crispa caulis
1600 mg, Orthosiphon stamineus folium 750 mg, and
Phyllanthus niruri folium 750 mg; in 10% fructoseinduced white rats Sprague Dawley. Systolic (SBP) and
diastolic blood pressure (DBP) were measured weekly
non-invasively using IITC life science. While the activity
of SOD, level of GSH, and malondialdehyde (MDA) in
the kidneys of rats measuring by spectrophotometer.
MATERIALS
Jamu B was purchased from herbal medicine shops in
North Jakarta. Thirty white rats Sprague Dawley (two
months old, weight 175-300 grams, healthy, and not
disabled) were obtained from the Faculty of Veterinary
Bogor Agricultural Institute, surgical instrument
(minor set), beaker glass, drinking bottle, stirring rod,
centrifuge, container box, freezer temperature -200 C, rat
cage, cuvette, non-invasive Mouse Rat Blood Pressure
(MRBP) IITC Life Science® system, digital balance,
dropper, glass pot, mouse probe, spectrophotometer
(Genesys), Sartorius®, Eppendorf tube (Sartorius®),
plastic clip, and vortex. Fructose (Merck), physiological
NaCl, PBS solution pH 7.4, trichloroacetic acid
(TCA), thiobarbituric acid (TBA), Ransod kit (Randox
Laboratories Ltd), dithiobisnitrobenzoat (DTNB)
solution, and sodium pentobarbital.
METHODS
Sample Preparations
Jamu B, which indicates lower blood pressure and blood
glucose levels, is available in the market in 6 g sealed
packets. The Jamu solution was made as stated in the
instructions by brewing into hot water to roughly 100 ml
and consumed two times on the same day. Experimental
dosages for this study were selected based on the packet
content of 6 g per human being. The average weight of a
human being taken is 50 kg, and the standard weight of
a rat is 250 g. The various doses for experimental were
0.12, 0.24, and 0.36 gram per kg body weight of rats.
The solution was given orally to rats based on group
division using a feeding tube (Nahar et al., 2013).
Experimental Design
This research has received approval from the Universitas
Esa Unggul health research ethics committee with
approval number 0161-20.152/DPKEKEP/FINALENUEUN/2020. Rats were acclimatized and divided
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into six groups; Jamu groups at a dose of 0.12 g/kg
BW (B1), 0.24 g/kg BW (B2), 0.36 g/kg BW (B3), the
captopril control group (C) with a dose of 0.0005 g/kg
BW, negative control group (D) (only 10% fructose),
and normal control group (E) (a healthy rats). 500 ml
of 10% fructose solution was given in a drink bottle
every day for each group except for group E. At the 9th
and 10th weeks, the rats were given treatment according
to the group division. Blood pressure and body weight
were measured every week (Eff et al., 2021). At the
beginning of the 11th week, the rats were anesthetized
with sodium pentobarbital at a 50 mg/kg BW dose, then
sacrificed, and the kidneys were removed. The kidneys
were homogenized using PBS solution pH 7.4, then
vortexed and centrifuged at 3000 rpm for 10 minutes.
The supernatant was separated and stored in a freezer at
-20 °C before measuring SOD activity, GSH levels, and
MDA levels (Kum et al., 2007).
SOD Activity Measurement
SOD activity was measured using a Ransod kit and read
with a spectrophotometer (Genesys) at a wavelength of
505 nm. The initial absorbance (A1) was read after 30
seconds, and the final absorbance (A2) was read after
3 minutes. The percentages inhibited by standards and
samples were determined using the RANSOD kit’s
superoxide dismutase instructions, and an inhibition
percent curve was created. The specific activity is
calculated from the standard curve (U/mL) divided by
protein concentration (mg/mL) (Farahnak et al., 2013).
GSH Levels Measurement
50 L of kidney homogenate was added to 200 l of 5%
TCA, then vortexed. After that, it was centrifuged and
added 25 L of DTNB and 1750 L of phosphate buffer
pH 7.4, then allowed to stand for 1 hour. The reaction
between DTNB and glutathione will produce 5′-thio2-nitrobenzoic acid (TNB) yellow with glutathione
disulfide (GSSG). By interacting with GSH to generate
GSSG, glutathione peroxide catalyzes the reduction
of H2O2 to H2O. The absorbance was measured using
a spectrophotometer at a wavelength of 412 nm and
compared with the absorbance of the standard glutathione
solution. The enzyme activity was expressed as units/mg
of protein (Abarikwu et al., 2017).
MDA Level Measurement
200 µl of homogenate was added to 1800 L of distilled
water and 1 mL of 20% TCA, then vortexed and
centrifuged at 3000 rpm for 10 minutes. The supernatant
formed was taken and added 2 mL of 0.67% TBA.
Then it was vortexed again and heated at 100 °C for
10 minutes. Color absorption was measured using a
spectrophotometer at a wavelength of 530 nm. MDA
levels were calculated using the MDA standard curve
(Abarikwu et al., 2017).
E-ISSN 2477-0612
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Figure 1. Mean of body weight (kg) for ten weeks from each treatment group. B1:
Jamu group at a dose of 0.12 g/kg BW; B2: Jamu group at a dose of 0.24 g/kg BW;
B3: Jamu group at a dose of 0.36 g/kg BW; C: captopril group at a dose of 0.1 g/kg
BW; D: negative control group; E: normal control group.
Data Analysis
The measurements of body weight, SOD activity, MDA
levels, and GSH were analyzed statistically using the
ANOVA test and multiple comparisons to determine
differences between treatment groups. Data analysis was
carried out using SPSS software version 26. The p-value
of <0.05 was considered statistically significant.
RESULTS AND DISCUSSION
The results of the mean body weight measurement
(Figure 1) showed that the average body weight in the
first week was 207.5 grams and increased to 266.5 grams
in the eighth week. Weight gain occurred by 28.5% in
all treatment groups, while in the normal control group,
there was an increase of 18% from the first week to the
eighth week after administration of fructose 10%. All the
treatment groups were statistically significant compared
to the normal control group in terms of body weight,
indicating that fructose affected weight gain. This is
similar to the study conducted by Sandeva et al. in rats
induced by 20% fructose for eight weeks that showed an
increase in body weight, length, and body fat. Köseler et
al. also showed that the administration of fructose 10%
and 30% in rats for six weeks had gained more weight
than in the group given glucose 10%. Uncontrolled
fructose consumption triggers weight gain and disrupts
the metabolic profiles, which contributes to the high
risk of obesity and metabolic syndrome (Köseler et al.,
2018). Weight gain is accompanied by increased fat
accumulation and circulating triglyceride levels (Köseler
et al., 2018). Moreover, high fructose intake will interfere
with the secretion and production of neuropeptides, such
as ghrelin and leptin, affecting appetite control (Sandeva
et al., 2015).
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Furthermore, excessive fructose consumption induces
hyperglycemia and hypertension (Yanti et al., 2014) (Yanti
et al., 2015). The mechanism by which fructose causes these
metabolic syndromes is influenced by renin-angiotensinaldosterone (RAS) activity (Kim et al., 2020). RAS is
a significant regulator of blood pressure; electrolyte
balance; and endocrine functions, such as controlling
the nervous system, kidneys, and cardiovascular system.
In this study, we measured the systolic and diastolic
blood pressure to evaluate the antihypertensive activity
of Jamu B (Figures 2a and 2b). The results of blood
pressure measurements in all treatment groups and
the normal control group showed an increase in blood
pressure, both systolic and diastolic, starting from the
third week of fructose administration, except in the
normal control group. Induction of 10% fructose in rats
for eight weeks showed an increase in blood pressure
in the treatment groups, and the administration of Jamu
B for two weeks caused a decrease in blood pressure.
In the negative control group (D), systolic blood
pressure increased until fructose administration stopped,
but the diastolic blood pressure remained the same.
Interestingly, the administration of Jamu B (B1, B2, and
B3) and captopril have shown a decrease in systolic blood
pressure, which was not significantly different from the
normal control group. Our results were in line with the
previous research by Eff et al., by which 10% fructose
administration in rats for eight weeks has increased blood
pressure and was reduced following the consumption of
antihypertensive therapy in the first and second week of
treatment (Eff et al., 2021). Another study also showed
that the administration of 66% fructose for two weeks
could increase blood pressure from 124 mmHg to 145
mmHg (Hwang et al., 1987).
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(a)

(b)

Figure 2. (a) Mean of systolic blood pressure (mmHg) within ten weeks for
each treatment group. (b) Mean of diastolic blood pressure (mmHg) within
ten weeks for each treatment group. B1: Jamu group at a dose of 0.12 g/kg
BW; B2: Jamu group at a dose of 0.24 g/kg BW; B3: Jamu group at a dose
of 0.36 g/kg BW; C: captopril group at a dose of 0.1 g/kg BW; D: negative
control group; E: normal control group.
Uncontrolled fructose intake has also been reported
to cause chronic kidney disease characterized by
renal hypertrophy with tubular cell proliferation and
tubulointerstitial injury, resulting in renal dysfunction
(Choi et al., 2011). The research conducted by Bratoeva
et al. showed an increase in kidney weight of 26% in
Wistar rats induced by 35% fructose for 16 weeks
(Bratoeva et al., 2017). Similarly, we found an increase
of 2.8% in kidney weight in the negative control group,
indicating hypertrophy or increased cell size in the kidney
organs due to the induction of fructose. We suggest that
the difference in kidney weight was influenced by the
animal species, the concentration of fructose used, and
the duration of fructose consumption. Interestingly, we
discovered that the Jamu B treatment at all doses was
considerably reduced kidney weight compared with the
negative control group. The percentage of the reduction
in kidney weights for B1, B2, B3, and captopril were
21.46%, 20.54%, 26,06%, and 9.13%, respectively
(Table 1) where B3 showed a significant reduction even
compared with captopril (p=0.015).

The effectiveness of Jamu B treatments in reducing
kidney damage was associated with the ability of its
antioxidant activity. Several studies have shown that
fructose consumption could increase lipid peroxidation
levels and decrease antioxidant enzyme activity in the
kidneys (Choi et al., 2011; Bratoeva et al., 2017). We
confirmed this towards an increase in MDA levels (9.79 ±
1.73 nmol/mL), a decrease in SOD activity (88.10 ± 6.43
U/mL), and GSH levels (0.19 ± 0.065 nmol/mg protein)
in the kidneys only in the negative control group (Table
1). Under normal conditions, free radicals can be formed
slowly. When the amount endogenous antioxidants
is insufficient to overcome the excess of free radicals,
oxidative stress occurs, leading to lipid peroxidation.
MDA is a product of lipid peroxidation (Ayala et al.,
2014). The study conducted by Bulboacă et al. showed
that the induction of 10% fructose for 12 weeks increased
MDA levels in the non-treated group (Bulboacă et al.
2016). Giving Jamu B treatments at all doses caused a
decrease in MDA levels. Surprisingly, the treatment dose
of 0.36 g/kg BW (B3) reduced the highest MDA level
E-ISSN 2477-0612
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Table 1. Comparison of kidney weight, SOD activity, GSH levels, and MDA levels among treatment groups
No.

Group

Kidney Weight
(gram)

SOD Activity
(U/mL)

GSH Level
(nmol/mg protein)

MDA Level
(nmol/mL)

1.
2.
3.
4.
5.
6.

B1
B2
B3
C
D
E

1.72 ± 0.17*
1.74 ± 0.07*
1.62 ± 0.14
1.99 ± 0.15**
2.19 ± 0.37
2.13 ± 0.36

108.03 ± 6.06*
129.19 ± 6.32*
175.63 ± 8.49*
221.84 ± 23.26*,**
88.10 ± 6.43
215.55 ± 10.55

0.25 ± 0.016**
0.40 ± 0.007*,**
0.55 ± 0.012
0.43 ± 0.037*
0.19 ± 0.065
0.51 ± 0.133

7.74 ± 0.74
5.76 ± 0.30
2.98 ± 0.23*,**
3.40 ± 0.45
9.79 ± 1.73
3.06 ± 0.12

Data presented as mean ± SD. (*) = significant difference with D group (negative control) (p<0.05); B1: Jamu group at a dose of 0.12 g/
kg BW; B2: Jamu group at a dose of 0.24 g/kg BW; B3: Jamu group at a dose of 0.36 g/kg BW; C: captopril group at a dose of 0.1 g/kg
BW; D: negative control group; E: normal control group.

by 2.98 ± 0.23 nmol/mL compared to B1 (7.74 ± 0.74
mmol/mL), B2 (5.76 ± 0.30 mmol/mL), and captopril
(3.40 ± 0.45 mmol/mL). Moreover, the statistical tests
results also showed a significant difference between B3
and the negative control group (p<0.001), and there was
no significant difference compared to the captopril group
(p=0.273).
The renal GSH levels showed that the negative control
group had the lowest GSH levels, around 0.19 ± 0.065
nmol/mg protein. The decrease in GSH levels indicates
that the induction of 10% fructose increases free radicals
in the kidney, thereby depleting endogenous antioxidant
defenses. The study conducted by Bratoeva et al. showed
a decrease in GSH levels in rats after being given 35%
fructose for 16 weeks compared to the control group
(Bratoeva et al., 2017). Choi et al. also proved that
fructose induction for ten weeks reduced GSH levels
(Choi et al., 2011). The statistical tests on GSH levels
showed no significant difference between B2 and B3
with the captopril group and the normal control group
(p>0.05).
The measurement of SOD activity in kidneys showed that
the captopril group had the highest SOD activity (221.84
± 23.26 U/mL) compared to Jamu B groups at all doses
and the negative control group. These results indicate that
the administration of captopril effectively maintained
and increased the activity of the SOD when oxidative
stress occurs. Captopril reduces lipid peroxidation
and free radicals by reducing NADPH oxidase and
expanding the regulation of antioxidant enzymes
(Karimani et al., 2018). Nevertheless, giving Jamu B
treatment with a dose of 0.36 g/kg BW (B3) (175.63
± 8.49 U/mL) had the closest value of SOD activity to
the captopril value (221.84 ± 23.26 U/mL) and normal
control group (215.55 ± 10.55 U/mL) compared to the
lower doses (B1 (108.03 ± 6.06 U/mL) and B2 (129.19
± 6.32 U/mL). Although the value was still lower than
the captopril group, the results of this study showed that
the administration of Jamu B was able to ward off free
E-ISSN 2477-0612

radicals by increasing SOD activity. The statistical tests
on SOD activity showed a significant difference between
the captopril group and Jamu B groups with a negative
control group and the normal control group (p<0.05).
However, there was no significant difference between
the captopril and the normal control group (p=0.4).
The presence of reactive oxygen species (ROS) in
the kidneys due to fructose consumption occurs
through the increased formation of uric acid. Fructose
is phosphorylated in the liver by fructokinase to
form fructose 1-phosphate. During this formation,
fructokinase activation requires phosphate and depletes
ATP. Furthermore, the enzyme aldolase B will break
down fructose 1-phosphate into dihydroxyacetone
phosphate (DHAP) and glyceraldehyde. When
fructose is consumed in excess, the phosphorylation by
fructokinase to form fructose 1-phosphate is fast, but the
reaction with aldolase B is slow. This condition causes
the accumulation of fructose 1-phosphate and a decrease
in intracellular fructose (Pi) and further activates AMP
deaminase (AMPD) and promotes the degradation of
AMP to inosine monophosphate (IMP). The result is an
increased rate of uric acid degradation and formation.
Uric acid can react with nitric oxide, causing a decrease
in dinucleotide phosphate oxidase (NOX) activation and
mitochondrial dysfunction. Uric acid also reacts with
radical molecules such as superoxide anion, resulting in
oxidative stress (Caliceti et al., 2017).
In addition, the decrease in SOD activity in the negative
control group described the abundance of free radicals
in the kidneys induced by fructose at 10%, giving
an extended time for uric acid levels to rise twice.
This increase can reduce nitric oxide, which results in
endothelial dysfunction (Bratoeva et al., 2017). Studies
with fructose-induced animal models have shown
decreased endothelial nitric oxide, increased oxidative
stress, and renin-angiotensin-aldosterone activation
associated
with
fructose-induced
hypertension
(Nakagawa et al., 2020). Moreover, oxidative stress
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causes hypertension and increased superoxide anion
and hydrogen peroxide free radicals (Tran et al., 2009;
Zhang et al., 2017). The research of Choi et al. also
showed a decrease in SOD activity in 65% fructoseinduced rats for ten weeks (Choi et al., 2011). SOD is
one of the first defense enzymatic antioxidants. There
are three types of SOD; Cu/Zn-SOD, which is located
in the cytoplasm and other cell organelles; Mn-SOD,
which is located in the mitochondria; and Fe-SOD,
which is found in prokaryotes and plant chloroplasts
(Ighodaro & Akinloye, 2018). The SOD enzyme will
catalyze the superoxide anion free radicals produced
in the formation of hypoxanthine and xanthine by the
xanthine oxidase enzyme during uric acid construction.
This superoxide anion will be converted into hydrogen
peroxide (H2O2) and oxygen (O2) by SOD. ROS that has
not been overcome by SOD but has attacked lipids will
form MDA, the end product of lipid peroxidation and a
marker of oxidative stress. Meanwhile, when GSH reacts
with GSHPx, it will reduce H2O2 to oxidized glutathione
(GSSG) and water (H2O). Three enzymes that act as
antioxidants are catalase, glutathione peroxidase, and
SOD. However, the work of these endogenous enzymes
is insufficient when there is an excess of free radicals in
the body (Santos-Sánchez et al., 2019).
Nevertheless, Jamu B contains various natural substances
rich in antioxidants, including Curcuma xanthorriza
rhizome 1500 mg, Andrographis paniculate herb 1200
mg, Tinospora crispa caulis 1600 mg, Orthosiphon
stamineus folium 750 mg, and Phyllanthus niruri folium
750 mg. Hence, this herbal medicine could effectively
tackle the abundance of free radicals produced by
prolonged fructose 10% in rats. The content of phenolic
compounds in flavonoids and tannins in Jamu B has
antioxidant abilities to inhibit free radicals in-vitro
(Eff, Rahayu, et al., 2020) by donating hydrogen atoms
from their hydroxyl groups, chelating metal ions, and
inhibiting LDL oxidation (Francenia Santos-Sánchez et
al., 2019).
Curcuma xantorrhizae (Temulawak), containing
curcumin compounds and essential oils, has also known
to have the potential as antioxidants, antibacterial,
anti-inflammatory, anticancer, hepatoprotective, and
antidyslipidemic (Rosidi et al., 2016). Research by
Bulboacă et al. showed that administration of curcumin
in fructose 10%-induced rats lowers blood pressure,
improves lipid profile, and works as hepatoprotective
(Bulboacă et al., 2016).
Andrographis paniculata herb (Sambiloto) has
been reported to have pharmacological activities,
including antioxidant, anti-inflammatory, antidiabetic,
hepatoprotective, antibacterial, and antiviral. Sambiloto
contains active compounds andrographolide and
flavonoids (Chao & Lin, 2010). The antioxidant activity
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of Andrographis paniculata works by increasing the
enzymes, SOD, catalase, and GSH. This plant extract
also can inhibit lipid peroxidation by reducing levels of
TBA reactive substances in the kidneys of diabetic rats
(Zhang and Tan, 2000). Andrographolide compounds
minimize the formation of reactive oxygen species
(ROS), thereby reducing oxidative stress (Jayakumar et
al., 2013).
Phyllanthus niruri folium (Meniran) contains
flavonoids, alkaloids, tannins, essential oils, glycosides,
and anthraquinones. This plant can be an antibacterial,
antidiabetic, and immunomodulator (Da et al., 2016). The
presence of quercetin compounds makes the antioxidant
activity of Phyllanthus niruri folium extract stronger
than vitamin E (Da et al., 2016). P. niruri water extract
was reported to have antioxidant activity that can reduce
the formation of free radicals and increase the activity
of endogenous enzymes in the kidney. Administration
of 200 mg/kg BW and 400 mg/kg BW doses increased
SOD activity in the kidneys by 43.02 % and 79.93%
and increased renal GPx by 18.94% and 35.78% in rats
induced with diabetes, respectively (Giribabu et al.,
2014).
Tinospora crispa (brotowali) has pharmacological activities,
including anti-inflammatory, immunomodulatory, cytotoxic,
hypoglycemic, and antioxidant. Brotowali contains
chemical compounds of alkaloids, flavonoids, tannins,
and triterpenoids (Ahmad et al., 2016). Tinospora
crispa aqueous extract showed high antioxidant activity
comparable to butylhydroxytoluene (BHT) and vitamin
C. The presence of phenolic compounds in this plant can
capture free radicals and prevent oxidative stress (Ahmad
et al., 2016). Flavonoids catch free radicals by stabilizing
ROS by reacting with reactive radical compounds,
increasing metal chelating activity, and activating
antioxidant enzymes. Flavonoids donate hydrogen
atoms, and their antioxidant activity is influenced by the
number and position of hydroxyl groups (Warsinah et
al., 2020).
Orthosiphon stannous folium (Cat’s whiskers leaf)
has been widely used as an alternative therapy for
hypertension. This plant extract contains several
bioactive
compounds,
including
polyphenols,
terpenoids, diterpenoids, triterpenoids. The presence of
these polyphenolic compounds shows antioxidant and
antihypertensive activity. Administration of Orthosiphon
leaf extract at a dose of 250 mg/kg BW for 14 days
was able to reduce systolic blood pressure in animal
models of hypertension. A dose of 250 mg/kg BW was
an optimal antihypertensive dose than 500 mg/kg BW
and 1000mg/kg BW. The efficacy of orthosiphon as
an antihypertensive is similar to irbesartan 20 mg/kg
(Azizan, 2012).
E-ISSN 2477-0612
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Therefore, with all the abundant antioxidant agents in this
Jamu, we observed that administration of Jamu B with
doses of 0.12 g/kg BW, 0.24 g/kg BW, and 0.36 g/kg BW
could reduce blood pressure, MDA levels, increase SOD
activity, and GSH level in rats induced by 10% fructose.
The higher dose of 0.36 g/kg BW of Jamu B showed
better results in lowering MDA levels, increasing SOD
activity, and increasing GSH levels comparable to
captopril due to more active metabolite compounds.
These results follow the research of Eff et al., which
shows that the higher the dose of antihypertensive jamu
consists of Phaleria macrocarpa, Gynura procumbens,
Imperata cylindrica, Centella asiatica, and Syzygium
polyanthum, the lower blood pressure is (Eff et al.,
2021). Nevertheless, further studies need to be taken to
analyze the subchronic toxicity of this herbal medicine
and evaluate renal histopathological examinations for
kidney function.
CONCLUSION
The administration of Jamu B containing Curcuma
xanthorriza rhizome 1500 mg, Andrographis paniculata
herb 1200 mg, Tinospora crispa caulis 1600 mg,
Orthosiphon stamineus folium 750 mg, and Phyllanthus
niruri folium 750 mg at doses of 0.12 g/kg BW, 0.24
g/kg BW, and 0.36 g/kg BW had antihypertensive and
antioxidant effects in 10% fructose-induced rats.
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